Semax
A synthetic ACTH(4-10) analog studied for BDNF expression and neuroprotection.
Research Overview
Semax is a synthetic heptapeptide based on the ACTH(4-10) fragment, modified for stability. Its principal research property is upregulation of brain-derived neurotrophic factor (BDNF) and its receptor TrkB, studied in neuronal-culture and neuroprotection models.
Additional investigations examine effects on dopaminergic and serotonergic signaling and inhibition of enkephalin-degrading enzymes. All work is in research models.
Specifications
| Compound | Semax (ACTH(4-7) analog) |
| Classification | Cognitive research compound |
| Molecular weight | 813.94 g/mol |
| Sequence / Form | Met-Glu-His-Phe-Pro-Gly-Pro |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
